The latest data mark the first slowdown in rising obesity rates in the US over the past ten years, with GLP-1 obesity drugs such as Wegovy and Zepbound helping to achieve this. ...
The latest data mark the first slowdown in rising obesity rates in the US over the past ten years, with GLP-1 obesity drugs such as Wegovy and Zepbound helping to achieve this. ...
Join our subscribers list to get the latest news, updates and special offers delivered directly in your inbox.